Literature DB >> 14561237

Symptoms of infection and acute mountain sickness; associated metabolic sequelae and problems in differential diagnosis.

Damian M Bailey1, Bruce Davies, Linda M Castell, David J Collier, James S Milledge, David A Hullin, Paul S Seddon, Ian S Young.   

Abstract

Infections and acute mountain sickness (AMS) are common at high altitude, yet their precise etiologies remain elusive and the potential for differential diagnosis is considerable. The present study was therefore designed to compare clinical nonspecific symptoms associated with these pathologies and basic changes in free radical and amino-acid metabolism. Nineteen males were examined at rest and after maximal exercise at sea level before (SL(1)/SL(2)) and following a 20 +/- 5 day ascent to Kanchenjunga base camp located at 5100 m (HA). Four subjects with symptoms consistent with an ongoing respiratory and recent gastrointestinal infection were also diagnosed with clinical AMS on the evening of day 1 at HA. These and six other subjects recovering from symptoms consistent with a respiratory infection presented with a greater increase (HA minus SL(1)) in AMS scores and resting venous concentration of lipid hydroperoxides (LH) and in total creatine phosphokinase and ratio of free tryptophan/branched chain amino acids, and greater decrease in glutamine (Gln) compared to healthy controls (n = 9, p < 0.05). The decrease in Gln was consistently related to the altitude/exercise-induced increase in LH (r = -0.69/r = -0.45; p < 0.05) and altitude-induced increase in myoglobin (r = -0.73, p < 0.05). These findings highlight the potential for the misdiagnosis of altitude illness due to the similarity of nonspecific constitutional symptoms associated with infection and AMS. Both conditions were characterized by parallel changes in peripheral biomarkers related to free-radical, skeletal muscle damage and amino acid metabolism. While clearly not establishing cause and effect, free radical-mediated changes in peripheral amino acid metabolism known to influence immune and cerebral serotoninergic function may enhance susceptibility to and/or delay recovery from altitude illness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561237     DOI: 10.1089/152702903769192278

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  5 in total

1.  Prediction of the susceptibility to AMS in simulated altitude.

Authors:  Martin Burtscher; Christoph Szubski; Martin Faulhaber
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

Review 2.  Exercising in environmental extremes : a greater threat to immune function?

Authors:  Neil P Walsh; Martin Whitham
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 3.  High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine.

Authors:  Michael Grocott; Hugh Montgomery; Andre Vercueil
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

4.  Acute mountain sickness, arterial oxygen saturation and heart rate among Tibetan students who reascend to Lhasa after 7 years at low altitude: a prospective cohort study.

Authors:  Espen Bjertness; Tianyi Wu; Hein Stigum; Per Nafstad
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

5.  Effects of Repetitive Altitude Training on Salivary Immunoglobulin A Secretion in Collegiate Swimmers.

Authors:  Koichi Watanabe; Subrina Jesmin; Yosuke Murase; Tsuyoshi Takeda; Takahisa Shiraki; Yasuo Sengoku
Journal:  J Clin Med Res       Date:  2019-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.